Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatiana Galperine

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|August 22, 2019
<i>Clostridioides difficile</i>: diagnosis and treatmentsBenoit Guery, Tatiana Galperine, Frédéric Barbut
Expert Opinion on Biological Therapy|June 28, 2022
Fecal microbiota transplantation: a review on current formulations in <i>Clostridioides difficile</i> infection and future outlooksAdèle Rakotonirina, Tatiana Galperine, Eric Allémann
Antimicrobial Agents and Chemotherapy|September 19, 2019
Phenotypic, biochemical and genetic analysis of KPC-41, a KPC-3 variant conferring resistance to ceftazidime-avibactam and exhibiting reduced carbapenemase activityLinda Mueller, Amandine Masseron, Guy Prod'Hom, et al.
Gut Microbes Reports|March 30, 2026
Resolution of long-term severe irritable bowel syndrome following fecal microbiota transplantation: A case report and microbiota analysisElena Montenegro-Borbolla, Jeanine Wakim El-Khoury, Claire Bertelli, et al.
AIDS (London, England)|May 16, 2007
Key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patientsConstance Delaugerre, Dominique Mathez, Gilles Peytavin, et al.
Plos One|January 20, 2017
Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in FranceEmilie Baro, Tatiana Galperine, Fanette Denies, et al.
International Journal of Pharmaceutics|April 19, 2023
Dry alginate beads for fecal microbiota transplantation: From model strains to fecal samplesAdèle Rakotonirina, Tatiana Galperine, Maxime Audry, et al.
Journal of Clinical Medicine|July 9, 2022
Treatment and Outcomes of <i>Clostridioides difficile</i> Infection in Switzerland: A Two-Center Retrospective Cohort StudyParaskevas Filippidis, Eleftheria Kampouri, Maximilian Woelfle, et al.
Infection|January 26, 2017
Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University HospitalMarie Pichenot, Rozenn Héquette-Ruz, Remi Le Guern, et al.
Swiss Medical Weekly|September 28, 2023
Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practiceLaura Rossier, Christoph Matter, Emanuel Burri, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|August 22, 2019
<i>Clostridioides difficile</i>: diagnosis and treatmentsBenoit Guery, Tatiana Galperine, Frédéric Barbut
Expert Opinion on Biological Therapy|June 28, 2022
Fecal microbiota transplantation: a review on current formulations in <i>Clostridioides difficile</i> infection and future outlooksAdèle Rakotonirina, Tatiana Galperine, Eric Allémann
Antimicrobial Agents and Chemotherapy|September 19, 2019
Phenotypic, biochemical and genetic analysis of KPC-41, a KPC-3 variant conferring resistance to ceftazidime-avibactam and exhibiting reduced carbapenemase activityLinda Mueller, Amandine Masseron, Guy Prod'Hom, et al.
Gut Microbes Reports|March 30, 2026
Resolution of long-term severe irritable bowel syndrome following fecal microbiota transplantation: A case report and microbiota analysisElena Montenegro-Borbolla, Jeanine Wakim El-Khoury, Claire Bertelli, et al.
AIDS (London, England)|May 16, 2007
Key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patientsConstance Delaugerre, Dominique Mathez, Gilles Peytavin, et al.
Plos One|January 20, 2017
Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in FranceEmilie Baro, Tatiana Galperine, Fanette Denies, et al.
International Journal of Pharmaceutics|April 19, 2023
Dry alginate beads for fecal microbiota transplantation: From model strains to fecal samplesAdèle Rakotonirina, Tatiana Galperine, Maxime Audry, et al.
Journal of Clinical Medicine|July 9, 2022
Treatment and Outcomes of <i>Clostridioides difficile</i> Infection in Switzerland: A Two-Center Retrospective Cohort StudyParaskevas Filippidis, Eleftheria Kampouri, Maximilian Woelfle, et al.
Infection|January 26, 2017
Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University HospitalMarie Pichenot, Rozenn Héquette-Ruz, Remi Le Guern, et al.
Swiss Medical Weekly|September 28, 2023
Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practiceLaura Rossier, Christoph Matter, Emanuel Burri, et al.
Pageof 2